Specific Delivery Platform Provides Promising Gene Therapy Against Neurodegenerative…
Due to BBB, achieving the delivery of this ASO therapy with systemic dosing and adequate concentrations in the central nervous system (CNS) has been difficult. ‘Specific group of drugs …